美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Gyre Therapeutics

9.11

+0.02000.22%

盤後：8.85-0.2600-2.85%19:54 EDT

成交量：9.73萬

成交額：87.60萬

市值：7.86億

市盈率：182.20

高：9.36

開：9.08

低：8.87

收：9.09

資料載入中...

總覽公司新聞資訊公告

Gyre Therapeutics, Inc.盤中異動大幅跳水5.04%

Gyre Therapeutics, Inc.盤中異動股價大漲5.87%報12.39美元

異動解讀 | Gyre Therapeutics盤中大漲5.2%,潛在治療藥物前景靚眼

Gyre Therapeutics, Inc.盤中異動臨近午盤急速上漲5.20%報12.24美元

Gyre Therapeutics, Inc.盤中異動股價大漲5.93%

Gyre Therapeutics, Inc.盤中異動下午盤快速下跌5.02%

Gyre Therapeutics, Inc.2024財年第三財季實現淨利潤1.12百萬美元，同比增加170.89%

Gyre Therapeutics, Inc.盤中異動股價大跌5.00%

Gyre Therapeutics, Inc.盤中異動早盤股價大漲5.07%報17.65美元

Gyre Therapeutics, Inc.盤中異動早盤大幅拉昇5.21%

Gyre Therapeutics, Inc.盤中異動早盤股價大漲5.33%報14.83美元

Gyre Therapeutics, Inc.盤中異動早盤急速下跌5.16%

Gyre Therapeutics, Inc.盤中異動下午盤股價大漲5.01%

Gyre Therapeutics, Inc.盤中異動早盤急速上漲5.00%報12.40美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GYRE/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":9.11,"timestamp":1743192000000,"preClose":9.09,"halted":0,"volume":97310,"hourTrading":{"tag":"盘后","latestPrice":8.85,"preClose":9.11,"latestTime":"19:54 EDT","volume":967,"amount":8667.49,"timestamp":1743206094424},"delay":0,"floatShares":16648400,"shares":86332200,"eps":0.049999,"marketStatus":"休市中","change":0.02,"latestTime":"03-28 16:00:00 EDT","open":9.08,"high":9.36,"low":8.87,"amount":875969.43964,"amplitude":0.053905,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.049999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":9.09,"preHourTrading":{"tag":"盘前","latestPrice":8.94,"preClose":9.09,"latestTime":"06:48 EDT","volume":316,"amount":2797.17986,"timestamp":1743158918402},"postHourTrading":{"tag":"盘后","latestPrice":8.85,"preClose":9.11,"latestTime":"19:54 EDT","volume":967,"amount":8667.49,"timestamp":1743206094424},"volumeRatio":0.4146550367973485},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","floatShares":16648400,"roa":"8.38%","roe":"20.24%","lyrEps":0.142017,"volumeRatio":0.4146550367973485,"shares":86332200,"dividePrice":0,"high":9.36,"amplitude":0.053905,"preClose":9.09,"low":8.87,"week52Low":8.26,"pbRate":"12.42","psRate":"7.44","week52High":19,"institutionHeld":0.0314,"latestPrice":9.11,"eps":0.049999,"divideRate":0,"volume":97310,"delay":0,"ttmEps":0.049999,"open":9.08,"prevYearClose":12.1,"prevWeekClose":9.71,"prevMonthClose":11.6,"prevQuarterClose":12.1,"fiveDayClose":9.71,"twentyDayClose":11.6,"sixtyDayClose":12.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GYRE\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2488677099","title":"Gyre Therapeutics, Inc.盤中異動 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488677099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488677099?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 23:03","pubTimestamp":1733151818,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时03分，Gyre Therapeutics, Inc.股票出现异动，股价快速下挫5.04%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230338a266aaa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202230338a266aaa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"gpt_icon":0},{"id":"2487550478","title":"Gyre Therapeutics, Inc.盤中異動 股價大漲5.87%報12.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487550478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487550478?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 22:30","pubTimestamp":1732890625,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时30分，Gyre Therapeutics, Inc.股票出现波动，股价急速拉升5.87%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223025971aa62b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223025971aa62b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0},{"id":"1140323914","title":"異動解讀 | Gyre Therapeutics盤中大漲5.2%,潛在治療藥物前景靚眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1140323914","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140323914?lang=zh_tw&edition=fundamental","pubTime":"2024-11-27 00:44","pubTimestamp":1732639461,"startTime":"0","endTime":"0","summary":"生物制药公司Gyre Therapeutics今日盘中大涨5.2%,引起市场广泛关注。\n\n分析人士指出,该公司的重磅产品Hydronidone正在进行相关临床试验,旨在治疗代谢功能障碍相关的脂肪性肝炎和肝纤维化。如果试验取得成功,这款新药或将成为公司的重要收入来源。\n\n另外,公司还在中国区域拥有多款管线产品,包括吡非尼酮、F573、F528和F230等,业务布局多元化,未来发展潜力可期。投资者对Gyre Therapeutics的长远前景持乐观态度,因此推动股价今日出现大涨行情。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Gyre Therapeutics盘中大涨5.2%,潜在治疗药物前景靓眼","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GYRE"],"gpt_icon":0},{"id":"2486885657","title":"Gyre Therapeutics, Inc.盤中異動 臨近午盤急速上漲5.20%報12.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486885657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486885657?lang=zh_tw&edition=fundamental","pubTime":"2024-11-27 00:37","pubTimestamp":1732639027,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时37分，Gyre Therapeutics, Inc.股票出现波动，股价大幅拉升5.20%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127003707abe0f6a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127003707abe0f6a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GYRE"],"gpt_icon":0},{"id":"2486203886","title":"Gyre Therapeutics, Inc.盤中異動 股價大漲5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486203886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486203886?lang=zh_tw&edition=fundamental","pubTime":"2024-11-25 22:30","pubTimestamp":1732545039,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时30分，Gyre Therapeutics, Inc.股票出现波动，股价快速拉升5.93%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223039a2548b4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223039a2548b4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2485218659","title":"Gyre Therapeutics, Inc.盤中異動 下午盤快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485218659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485218659?lang=zh_tw&edition=fundamental","pubTime":"2024-11-23 03:06","pubTimestamp":1732302392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日03时06分，Gyre Therapeutics, Inc.股票出现波动，股价急速下挫5.02%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123030632971a8294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123030632971a8294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0},{"id":"2485419542","title":"Gyre Therapeutics, Inc.2024財年第三財季實現淨利潤1.12百萬美元，同比增加170.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485419542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485419542?lang=zh_tw&edition=fundamental","pubTime":"2024-11-22 00:00","pubTimestamp":1732204826,"startTime":"0","endTime":"0","summary":"11月22日，Gyre Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为1.12百万美元，同比增加170.89%；其中营业收入为25.49百万美元，每股基本收益为0.01美元。从资产负债表来看，Gyre Therapeutics, Inc.总负债26.77百万美元，其中短期债务694000.00美元，资产负债比为0.05，流动比率为3.73。机构评级：截至2024年11月22日，当前有1家机构对Gyre Therapeutics, Inc.目标价做出预测，其中目标均价为45.00美元，其中最低目标价为45.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000037abd50d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122000037abd50d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ"],"gpt_icon":0},{"id":"2483881492","title":"Gyre Therapeutics, Inc.盤中異動 股價大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483881492?lang=zh_tw&edition=fundamental","pubTime":"2024-11-13 22:43","pubTimestamp":1731508998,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时43分，Gyre Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322431998e425fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322431998e425fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2482085733","title":"Gyre Therapeutics, Inc.盤中異動 早盤股價大漲5.07%報17.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482085733?lang=zh_tw&edition=fundamental","pubTime":"2024-11-12 22:33","pubTimestamp":1731421994,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时33分，Gyre Therapeutics, Inc.股票出现异动，股价大幅拉升5.07%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222331498e42124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222331498e42124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2478648429","title":"Gyre Therapeutics, Inc.盤中異動 早盤大幅拉昇5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478648429?lang=zh_tw&edition=fundamental","pubTime":"2024-10-28 22:22","pubTimestamp":1730125339,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时22分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨5.21%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222220971a2ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028222220971a2ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2478939602","title":"Gyre Therapeutics, Inc.盤中異動 早盤股價大漲5.33%報14.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478939602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478939602?lang=zh_tw&edition=fundamental","pubTime":"2024-10-25 22:07","pubTimestamp":1729865266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时07分，Gyre Therapeutics, Inc.股票出现波动，股价大幅拉升5.33%。截至发稿，该股报14.83美元/股，成交量5826股，换手率0.01%，振幅2.63%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074698e3e845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522074698e3e845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0},{"id":"2477355532","title":"Gyre Therapeutics, Inc.盤中異動 早盤急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477355532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477355532?lang=zh_tw&edition=fundamental","pubTime":"2024-10-22 22:27","pubTimestamp":1729607264,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时27分，Gyre Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222274498e3dca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102222274498e3dca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2474048831","title":"Gyre Therapeutics, Inc.盤中異動 下午盤股價大漲5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474048831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474048831?lang=zh_tw&edition=fundamental","pubTime":"2024-10-12 01:35","pubTimestamp":1728668102,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日01时35分，Gyre Therapeutics, Inc.股票出现波动，股价快速拉升5.01%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120135029719fbc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120135029719fbc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"gpt_icon":0},{"id":"2472617023","title":"Gyre Therapeutics, Inc.盤中異動 早盤急速上漲5.00%報12.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472617023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472617023?lang=zh_tw&edition=fundamental","pubTime":"2024-10-03 23:18","pubTimestamp":1727968731,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日23时18分，Gyre Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。截至发稿，该股报12.40美元/股，成交量1.9306万股，换手率0.02%，振幅3.30%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.99%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032318519719e370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410032318519719e370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GYRE","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":3,"totalSize":46}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"GYRE","fiscalQuarterEnding":"2024/12","expectedEps":0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":0.01},{"date":"2025-02-18","symbol":"GYRE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739869200000,"name":null,"time":"盤前","dateTimestamp":1739854800000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"GYRE","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":0.02},{"market":"US","date":"2024-08-13","symbol":"GYRE","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":0.01},{"market":"US","date":"2024-05-09","symbol":"GYRE","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GYRE","date":"2025-03-28","current":70.412668,"percent":0.974026,"low":-11548.718266,"twenty":-30.971251,"median":-13.353241,"eighty":-10.90871,"high":95.122945,"avg":-1488.490577,"sd":3407.330192,"marketCap":850937097},"quantilePoints":[{"date":"2024-04-05","current":-15.607876,"twenty":-15.830217,"median":-15.617068,"eighty":-15.398378,"marketCap":1450486717},{"date":"2024-04-12","current":-31.76291,"twenty":-32.589325,"median":-21.429161,"eighty":-15.61523,"marketCap":1405212396},{"date":"2024-04-19","current":-29.754799,"twenty":-32.477335,"median":-30.585076,"eighty":-15.742078,"marketCap":1316372220},{"date":"2024-04-26","current":-31.531205,"twenty":-31.948274,"median":-30.797472,"eighty":-16.000876,"marketCap":1394961607},{"date":"2024-05-03","current":-27.239192,"twenty":-31.948274,"median":-30.778163,"eighty":-24.631989,"marketCap":1205080075},{"date":"2024-05-10","current":-14.851474,"twenty":-31.774495,"median":-30.223912,"eighty":-24.631989,"marketCap":1301657414},{"date":"2024-05-17","current":-14.909982,"twenty":-31.744918,"median":-29.754799,"eighty":-15.561911,"marketCap":1306785414},{"date":"2024-05-24","current":-12.302842,"twenty":-31.573048,"median":-28.630129,"eighty":-14.89828,"marketCap":1078282562},{"date":"2024-05-31","current":-8605.737804,"twenty":-32.075712,"median":-29.501562,"eighty":-15.108912,"marketCap":890160307},{"date":"2024-06-07","current":-8895.075775,"twenty":-32.90985,"median":-30.136978,"eighty":-15.311743,"marketCap":920088848},{"date":"2024-06-14","current":-9126.546144,"twenty":-8519.763095,"median":-30.585076,"eighty":-15.366351,"marketCap":944031680},{"date":"2024-06-21","current":-8961.210165,"twenty":-8885.155616,"median":-30.816781,"eighty":-15.424018,"marketCap":926929657},{"date":"2024-06-28","current":-8175.864257,"twenty":-8865.315298,"median":-30.894016,"eighty":-15.515947,"marketCap":845695047},{"date":"2024-07-05","current":-9688.68848,"twenty":-8961.210165,"median":-31.531205,"eighty":-15.611553,"marketCap":1002178559},{"date":"2024-07-12","current":-10424.433593,"twenty":-9151.346542,"median":-31.791873,"eighty":-15.679573,"marketCap":1078282562},{"date":"2024-07-15","current":-11094.044316,"twenty":-9210.867496,"median":-31.820836,"eighty":-15.710825,"marketCap":1147545756},{"date":"2024-08-02","current":-11548.718266,"twenty":-9298.495565,"median":-32.139431,"eighty":-15.742078,"marketCap":1194576320},{"date":"2024-08-09","current":-8374.267436,"twenty":-9189.373818,"median":-32.728348,"eighty":-16.000876,"marketCap":866217475},{"date":"2024-08-16","current":-10.635127,"twenty":-9134.812943,"median":-32.641458,"eighty":-15.61523,"marketCap":914301855},{"date":"2024-08-23","current":-11.421808,"twenty":-9126.546144,"median":-31.820836,"eighty":-15.175222,"marketCap":981932798},{"date":"2024-08-30","current":-13.672312,"twenty":-9020.73112,"median":-31.635813,"eighty":-14.375603,"marketCap":1175408659},{"date":"2024-09-06","current":-11.770337,"twenty":-8974.437045,"median":-30.942288,"eighty":-13.816505,"marketCap":1011895874},{"date":"2024-09-13","current":-14.920484,"twenty":-8961.210165,"median":-30.778163,"eighty":-13.696211,"marketCap":1282714046},{"date":"2024-09-20","current":-15.572509,"twenty":-8941.369845,"median":-30.223912,"eighty":-13.816505,"marketCap":1338768556},{"date":"2024-09-27","current":-13.909847,"twenty":-8923.182886,"median":-29.754799,"eighty":-13.90034,"marketCap":1195829555},{"date":"2024-10-04","current":-13.312158,"twenty":-8919.876167,"median":-28.630129,"eighty":-13.654308,"marketCap":1144446254},{"date":"2024-10-11","current":-12.327984,"twenty":-8904.995932,"median":-26.800559,"eighty":-13.325198,"marketCap":1059836795},{"date":"2024-10-18","current":-15.235629,"twenty":-8865.315298,"median":-15.915547,"eighty":-13.300875,"marketCap":1309807059},{"date":"2024-10-25","current":-15.300832,"twenty":-8830.594739,"median":-15.607876,"eighty":-13.325198,"marketCap":1315412510},{"date":"2024-10-31","current":-15.985457,"twenty":-8804.140979,"median":-15.617068,"eighty":-13.405529,"marketCap":1374269746},{"date":"2024-11-08","current":-16.365804,"twenty":-8779.340581,"median":-15.748988,"eighty":-13.558712,"marketCap":1406968211},{"date":"2024-11-15","current":-13.372591,"twenty":-8709.89947,"median":-15.77333,"eighty":-13.558712,"marketCap":1187780244},{"date":"2024-11-22","current":-11.353175,"twenty":-8602.431085,"median":-15.627389,"eighty":-13.295234,"marketCap":1008411696},{"date":"2024-11-29","current":-12.087508,"twenty":-8556.137012,"median":-15.590193,"eighty":-13.126615,"marketCap":1073636622},{"date":"2024-12-06","current":-10.111572,"twenty":-8387.494312,"median":-15.378053,"eighty":-12.781935,"marketCap":898130076},{"date":"2024-12-13","current":-9.449706,"twenty":-8374.267436,"median":-15.329691,"eighty":-12.475931,"marketCap":839341820},{"date":"2024-12-20","current":-10.299987,"twenty":-8344.506959,"median":-15.279098,"eighty":-12.329976,"marketCap":914865419},{"date":"2024-12-27","current":-12.686569,"twenty":-8225.465052,"median":-15.246496,"eighty":-12.302842,"marketCap":1126846431},{"date":"2025-01-03","current":-11.594732,"twenty":-8192.397854,"median":-15.235629,"eighty":-12.152426,"marketCap":1029867264},{"date":"2025-01-10","current":-9.29511,"twenty":-8179.170976,"median":-15.105225,"eighty":-11.98162,"marketCap":825610256},{"date":"2025-01-17","current":-10.435259,"twenty":-3290.168076,"median":-14.953086,"eighty":-11.68749,"marketCap":926880537},{"date":"2025-01-24","current":-10.242013,"twenty":-32.95233,"median":-14.893499,"eighty":-11.536758,"marketCap":909716083},{"date":"2025-01-31","current":-11.111618,"twenty":-32.786274,"median":-14.681409,"eighty":-11.380628,"marketCap":986956128},{"date":"2025-02-07","current":-12.319402,"twenty":-32.658836,"median":-14.539395,"eighty":-11.347378,"marketCap":1094233968},{"date":"2025-02-14","current":-11.382162,"twenty":-32.515952,"median":-14.451664,"eighty":-11.279742,"marketCap":1010986364},{"date":"2025-02-21","current":-12.135819,"twenty":-32.330588,"median":-14.072853,"eighty":-11.345445,"marketCap":1077927736},{"date":"2025-02-28","current":-10.90871,"twenty":-31.809251,"median":-13.976035,"eighty":-11.179254,"marketCap":968933450},{"date":"2025-03-07","current":-10.338636,"twenty":-31.758412,"median":-13.909847,"eighty":-11.12128,"marketCap":918298310},{"date":"2025-03-14","current":-11.556083,"twenty":-31.698577,"median":-13.789262,"eighty":-11.11355,"marketCap":1026434373},{"date":"2025-03-21","current":79.165838,"twenty":-31.423076,"median":-13.627303,"eighty":-11.045914,"marketCap":956719157},{"date":"2025-03-28","current":70.412668,"twenty":-30.971251,"median":-13.353241,"eighty":-10.90871,"marketCap":850937097}],"updateTime":1743373057736}}}